Anastasia Chrysostomou

Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker

Anastasia Chrysostomou, Eugenia Pedagogos, Lachlan MacGregor et al. · Clinical Journal of the American Society of Nephrology · 2006 · 210 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

DILTIAZEM IN RENAL ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORINE

Anastasia Chrysostomou, Rowan G. Walker, Graeme R. Russ et al. · Transplantation · 1993 · 77 citations

Medicine, Nephrology, Pharmacology +16

Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals

Emily Woolnough, Jennifer Hoy, Allen Cheng et al. · AIDS · 2018 · 20 citations

Medicine, Biostatistics, Nephrology +17

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus

Fabien B. Vincent, Rangi Kandane‐Rathnayake, Alberta Hoi et al. · Lupus · 2018 · 20 citations

Medicine, Immunology, Nephrology +16